What Private Equity Actually Wants in a Med Spa (The Roll-Up Playbook)

Why private capital is buying med spas at all

A decade ago, private equity rolled up dental practices, then dermatology, then veterinary clinics. The playbook is the same each time: buy fragmented, cash-pay, recurring-revenue businesses one at a time at low multiples, combine them into a platform, professionalize operations, and sell the whole thing at a much higher multiple. Med spas are the current target, and the runway is enormous. Private-equity firms own roughly 3% of the estimated 10,488 med spa locations in the US, which means the consolidation is early, not late.

If you're a buyer trying to compete with these firms, or a seller trying to become the business they want to buy, it pays to understand exactly what they're looking for. This is that list.

They want cash-pay, recurring revenue

Med spas are attractive to institutional buyers for one structural reason: patients pay out of pocket, on a schedule, for services they choose to repeat. No insurance reimbursement, no claims cycle, no payer risk. A membership program that bills monthly turns a discretionary purchase into predictable revenue, and predictable revenue is what earns a premium multiple.

This is why membership share drives price. A spa with 30% to 40% of revenue in memberships commands roughly 0.5x to 1.0x more than a comparable spa with none. Buyers aren't paying for the discount you give members. They're paying for the retention the membership proves.

They want to buy the business, not the operator

The single biggest thing PE buyers screen for is whether the business survives the founder leaving. If most of the revenue walks out the door with one injector, especially the owner, the business isn't a platform asset, it's a job. Buyers either pass or price it as a risk.

What they want to see instead: multiple productive providers, patients loyal to the brand and the location rather than to one person, and documented systems that let a new operator run the practice without the founder in the room. A spa built to run without its owner is worth far more to a buyer than one built around a star. If you're a seller, this is the work to start early; see provider concentration.

They want clean, verifiable numbers

Institutional buyers run a quality-of-earnings review on everything. They reconcile revenue to merchant processor data, expenses to bank statements, and every add-back to a source document. A spa with clean, accrual-based books and a defensible add-back schedule sails through. A spa with cash-basis shoebox accounting gets repriced or passed over, no matter how good the underlying business is.

Clean numbers also close faster, and speed matters to a buyer deploying capital on a clock. The easier you are to verify, the more they'll pay and the more certain the close.

They want a defensible position in a metro

PE platforms think in geographies. They'd rather own three strong spas in one metro than one spa each in three cities, because density lets them share marketing, staffing, and management. If your spa is a leader in its local market, or could anchor a buyer's entry into a metro they want, you're more valuable than your standalone numbers suggest.

This is also why a strong, assignable, long-term lease matters so much. The location is part of the asset, and a buyer building a regional footprint needs to know it stays put.

They want the medical structure to be clean

Every state regulates who can own and operate a medical practice. Buyers, especially non-physician PE firms, have to fit your business into a compliant structure, usually a professional corporation for the clinical side and a management services organization for the business side. If your medical director relationship, supervision chain, and entity structure are already clean and documented, you're an easy acquisition. If they're informal or non-compliant, you're a legal project the buyer has to fix, and they'll price that risk or walk. We explain the model in the MSO/PC structure and Corporate Practice of Medicine.

What they pay, by size

The multiple a buyer offers scales with the size and sophistication of the business. Rough current ranges:

The gap between a $400,000 spa at 3x and a $3M platform at 8x is the whole reason roll-ups exist. Buyers acquire small at low multiples and sell the combined platform at high ones. That spread, the "multiple arbitrage," is the return.

Who the actual buyers are

This isn't theoretical. Active platform consolidators in aesthetics include L Catterton (Ideal Image), Leonard Green Partners (Milan Laser), KKR (SkinSpirit), Freeman Spogli (VIO Med Spa), and Leon Capital (Advanced MedAesthetic Partners). In mid-2026, Reuters reported LaserAway running a sale process targeting a $2B-plus valuation against roughly $150M of EBITDA, implying a 13x to 14x multiple for a multi-state, cash-pay, membership-driven chain. That's the top of the market, and it's the exit these platforms are building toward.

For a seller, the takeaway is that the buyers are real, well-funded, and actively acquiring. For a buyer competing with them, the takeaway is that you win on the things they're slower at: local relationships, speed, and a willingness to buy the spas just below their size threshold.

How to become what they want

If you're a seller, the path is direct. Build recurring revenue. Diversify your providers. Clean your books. Lock your lease. Document your medical structure. Each one moves you toward the profile a platform buyer pays a premium for. The 12-month pre-sale plan sequences the whole thing.

If you're a buyer, the path is to find the off-market operators before the platforms do, in the size band where you can still buy at a reasonable multiple, and to move faster and more personally than a committee can.

Either way, it starts with knowing the numbers. Sellers can get a confidential valuation to see where they land on the table above. Qualified buyers can access off-market deal flow the platforms haven't reached yet.